-
1 week ago | 
dermatologytimes.com | Kaitlyn Bader
In a dynamic and interactive Dermatology Times Case-Based Roundtable event, Innovative Approaches in Vitiligo Treatment: Case-Based Strategies for Management, Michael Gold, MD, guided clinician attendees through 3 challenging vitiligo cases, reinforcing both the complexity of treatment and the emotional and social factors that affect therapeutic decisions.
-
2 weeks ago | 
dermatologytimes.com | Albert S. Chiou |Kaitlyn Bader
“This is the first time that a selective ITK inhibitor has been studied in atopic dermatitis or any human immune-mediated disease for that matter. I think this trial is a real step forward in giving us a potential new way to selectively target TH2 and TH17 with an oral medication with an acceptable safety profile,” said Albert Chiou, MD, MBA, in an interview with Dermatology Times.
-
3 weeks ago | 
dermatologytimes.com | Kaitlyn Bader
What does meaningful progress in atopic dermatitis (AD) look like in 2025? Is it new therapeutic classes, improved personalized treatment, or greater access to care? With AD research advancing at a pace previously seen in psoriasis, clinicians are increasingly asked to differentiate between drugs, patient profiles, disease severity, and inflammatory pathways. Beyond approvals, how are these advances reshaping patient care, and where is the specialty headed next?
-
1 month ago | 
dermatologytimes.com | Kaitlyn Bader
Corvus Pharmaceuticals recently announced new interim data for its randomized, double-blind, placebo-controlled phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis (AD) who have failed one prior topical or systemic therapy.
-
1 month ago | 
dermatologytimes.com | Raj Chovatiya |Kaitlyn Bader
“I introduce the idea of topical non-steroidals very early. I think that when you really try to emphasize the fact that topical steroids were made for certain things and not made for others, it makes that discussion a little easier when you try to introduce some of our newer options,” said Raj Chovatiya, MD, PhD, MSCI, in an interview with Dermatology Times.
-
1 month ago | 
dermatologytimes.com | Kaitlyn Bader
“Steroid phobia is at an all-time high, but if it had to happen at any time in history, I'm so glad it's now because we're prepared. We have other options that we can use to help manage our patients with atopic dermatitis,” said Lisa Swanson, MD, FAAD, while highlighting her recent Dermatology Times Case-Based Roundtable custom event titled, Navigating Atopic Dermatitis Treatment: Case-Based Discussions on Optimizing Management.
-
1 month ago | 
dermatologytimes.com | Raj Chovatiya |Kaitlyn Bader
“JAK inhibitors have really given us additional options for therapy in the last few years that we didn't have for our patients, particularly oral therapeutics, something that's been lacking in this disease space,” said Raj Chovatiya, MD, PhD, MSCI, in an interview with Dermatology Times.
-
1 month ago | 
dermatologytimes.com | Kaitlyn Bader
The 2025 American Academy of Dermatology (AAD) Annual Meeting brought together dermatology clinicians from around the globe in Orlando, Florida, for 5 days of clinical updates and networking. From March 7 to 11, this year’s AAD meeting featured more than 330 sessions with countless topics and therapeutic focuses. Dermatology Times was in Orlando conducting interviews with presenters to discuss the key data and take-home points they shared.
-
1 month ago | 
dermatologytimes.com | Raj Chovatiya |Kaitlyn Bader
“RAD is one-stop shop for everything happening in education, clinical practice, and research for atopic dermatitis,” said Raj Chovatiya, MD, PhD, MSCI, in an interview with Dermatology Times.
-
1 month ago | 
dermatologytimes.com | Kaitlyn Bader
“Dr Kwatra has built an impressive career. He has contributed invaluably to our understanding of complex dermatology conditions. His leadership in his field inspires his colleagues and is a beacon of hope for the families he serves,” said William F. Regine, MD, in an investiture ceremony honoring Shawn Kwatra, MD, as the newly endowed Dr. Joseph Warren Burnett Professor of Dermatology at the University of Maryland School of Medicine.
